Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections

Tao Yan,1,2 Qiuyan Wang,2 Chengcheng Ma,2 Xuan Teng,2 Zhen Gong,2 Wenwen Chu,2 Qiang Zhou,2 Zhou Liu1 1Department of Clinical Laboratory Center, Anhui Chest Hospital, Hefei, 230031, People’s Republic of China; 2Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui Medical Univer...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan T, Wang Q, Ma C, Teng X, Gong Z, Chu W, Zhou Q, Liu Z
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/phage-vbkpnhf0522-isolation-characterization-and-therapeutic-potential-peer-reviewed-fulltext-article-IDR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823858018596421632
author Yan T
Wang Q
Ma C
Teng X
Gong Z
Chu W
Zhou Q
Liu Z
author_facet Yan T
Wang Q
Ma C
Teng X
Gong Z
Chu W
Zhou Q
Liu Z
author_sort Yan T
collection DOAJ
description Tao Yan,1,2 Qiuyan Wang,2 Chengcheng Ma,2 Xuan Teng,2 Zhen Gong,2 Wenwen Chu,2 Qiang Zhou,2 Zhou Liu1 1Department of Clinical Laboratory Center, Anhui Chest Hospital, Hefei, 230031, People’s Republic of China; 2Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, People’s Republic of ChinaCorrespondence: Zhou Liu, Department of Clinical Laboratory Center, Anhui Chest Hospital, Hefei, People’s Republic of China, Email [email protected]: Klebsiella pneumoniae is a globally prevalent pathogen responsible for severe hospital- and community-acquired infections, and presents significant challenges for clinical management. Current therapeutic strategies are no longer able to meet the clinical needs; therefore, there is an urgent need to develop novel therapeutic strategies. This study aimed to evaluate the efficacy of phage therapy in treating bacterial infections.Methods: Isolated phage vB_Kpn_HF0522 and phage morphology were observed using transmission electron microscopy. Analysis of vB_Kpn_HF0522 characteristics, including optimal multiplicity of infection (MOI), one-step growth curve, host range, stability in different environments, and adsorption capacity. The phage genomic sequence was analyzed to explore evolutionary relationships. The effect of phage vB_Kpn_HF0522 on biofilms was assessed using crystal violet staining assay. The Galleria mellonella (G. mellonella) infection model and mouse infection models were established to evaluate the practical application potential of the phage and the fitness cost of phage-resistant bacteria.Results: Phage was isolated from hospital sewage for experimental studies. Genome analysis revealed that vB_Kpn_HF0522 is a double-stranded linear DNA virus. Biological characterization demonstrated that this phage specifically targets serotype K1 K. pneumoniae with an optimal multiplicity of infection (MOI) of 0.01, effectively disrupting biofilms and inhibiting bacterial growth. The bacterial growth rate remained largely unchanged after the phage resistance mutation, but mice infected with the mutant strain showed significantly higher survival rates than those infected with the wild-type strain. vB_Kpn_HF0522 increased the survival rate of infected G. mellonella from 12.5% to 75%, inhibited incisional surgical site infections and alleviated inflammatory response in mice.Conclusion: These findings indicate that vB_Kpn_HF0522 has significant potential for treating specific bacterial infections, and may serve as an antimicrobial agent for research and clinical anti-infective therapy.Keywords: phage vB_Kpn_HF0522, phage therapy, Klebsiella pneumoniae, phage resistance, incisional surgical site infection, biofilm
format Article
id doaj-art-f08c888bf4614d45a7dafd74834bc68c
institution Kabale University
issn 1178-6973
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj-art-f08c888bf4614d45a7dafd74834bc68c2025-02-11T17:30:55ZengDove Medical PressInfection and Drug Resistance1178-69732025-02-01Volume 18803818100006Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae InfectionsYan TWang QMa CTeng XGong ZChu WZhou QLiu ZTao Yan,1,2 Qiuyan Wang,2 Chengcheng Ma,2 Xuan Teng,2 Zhen Gong,2 Wenwen Chu,2 Qiang Zhou,2 Zhou Liu1 1Department of Clinical Laboratory Center, Anhui Chest Hospital, Hefei, 230031, People’s Republic of China; 2Department of Clinical Laboratory, the Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, People’s Republic of ChinaCorrespondence: Zhou Liu, Department of Clinical Laboratory Center, Anhui Chest Hospital, Hefei, People’s Republic of China, Email [email protected]: Klebsiella pneumoniae is a globally prevalent pathogen responsible for severe hospital- and community-acquired infections, and presents significant challenges for clinical management. Current therapeutic strategies are no longer able to meet the clinical needs; therefore, there is an urgent need to develop novel therapeutic strategies. This study aimed to evaluate the efficacy of phage therapy in treating bacterial infections.Methods: Isolated phage vB_Kpn_HF0522 and phage morphology were observed using transmission electron microscopy. Analysis of vB_Kpn_HF0522 characteristics, including optimal multiplicity of infection (MOI), one-step growth curve, host range, stability in different environments, and adsorption capacity. The phage genomic sequence was analyzed to explore evolutionary relationships. The effect of phage vB_Kpn_HF0522 on biofilms was assessed using crystal violet staining assay. The Galleria mellonella (G. mellonella) infection model and mouse infection models were established to evaluate the practical application potential of the phage and the fitness cost of phage-resistant bacteria.Results: Phage was isolated from hospital sewage for experimental studies. Genome analysis revealed that vB_Kpn_HF0522 is a double-stranded linear DNA virus. Biological characterization demonstrated that this phage specifically targets serotype K1 K. pneumoniae with an optimal multiplicity of infection (MOI) of 0.01, effectively disrupting biofilms and inhibiting bacterial growth. The bacterial growth rate remained largely unchanged after the phage resistance mutation, but mice infected with the mutant strain showed significantly higher survival rates than those infected with the wild-type strain. vB_Kpn_HF0522 increased the survival rate of infected G. mellonella from 12.5% to 75%, inhibited incisional surgical site infections and alleviated inflammatory response in mice.Conclusion: These findings indicate that vB_Kpn_HF0522 has significant potential for treating specific bacterial infections, and may serve as an antimicrobial agent for research and clinical anti-infective therapy.Keywords: phage vB_Kpn_HF0522, phage therapy, Klebsiella pneumoniae, phage resistance, incisional surgical site infection, biofilmhttps://www.dovepress.com/phage-vbkpnhf0522-isolation-characterization-and-therapeutic-potential-peer-reviewed-fulltext-article-IDRphage vb_kpn_hf0522phage therapyklebsiella pneumoniaephage resistanceincisional surgical site infectionbiofilm
spellingShingle Yan T
Wang Q
Ma C
Teng X
Gong Z
Chu W
Zhou Q
Liu Z
Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
Infection and Drug Resistance
phage vb_kpn_hf0522
phage therapy
klebsiella pneumoniae
phage resistance
incisional surgical site infection
biofilm
title Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
title_full Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
title_fullStr Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
title_full_unstemmed Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
title_short Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections
title_sort phage vb kpn hf0522 isolation characterization and therapeutic potential in combatting k1 klebsiella pneumoniae infections
topic phage vb_kpn_hf0522
phage therapy
klebsiella pneumoniae
phage resistance
incisional surgical site infection
biofilm
url https://www.dovepress.com/phage-vbkpnhf0522-isolation-characterization-and-therapeutic-potential-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT yant phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT wangq phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT mac phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT tengx phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT gongz phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT chuw phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT zhouq phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections
AT liuz phagevbkpnhf0522isolationcharacterizationandtherapeuticpotentialincombattingk1klebsiellapneumoniaeinfections